Sign in →

Test Code OXYCO OXYCODONE SCREEN WITH GC-MS CONFIRMATION, URINE

Additional Codes

Software Test Code
Label Text                                         OXYCO
EPIC LAB10898                          

Performing Laboratory

NorDx Laboratories

Useful For

Screening the detection of oxycodone and its metabolite, oxymorphone, in urine

Method Name

Enzyme Immunoassay (EIA)

Gas Chromatography-Mass Spectrometry (GC-MS) (If indicated)

Reference Values

Not Detected

EIA cutoff concentration: 100 ng/mL

 

GC-MS cutoff concentrations:

Codeine: < 25 ng/mL

Hydrocodone: < 25 ng/mL

Hydromorphone: < 25ng/mL

Oxycodone: < 25 ng/mL

Morphine: < 25 ng/mL

Oxymorphone: < 25 ng/mL

 

For help with interpretation please call: 877-323-0045

 

Please see test code OPUR for additional oxycodone confirmatory testing information.

Days and Times Test Performed

Monday through Friday

Report Available

1 Day

Specimen Type

Urine, Random

Preferred Container

Urine Cup

Preferred Volume

Urine, Random: 25 mL (Urine Cup)

Minimum Volume

Urine, Random: 10 mL (Urine Cup)

Specimen Collection and Handling

Collect random urine and send refrigerated in a clean, non-sterile urine container.

Specimen Stability Information

Specimen Type: Urine, Random

Refrigerated: 7 Days

Add On Capable

Not Permitted

Advance Beneficiary Notice Requirements

This test, when ordered on Medicare patients, is subject to the National Coverage Determination (NCD) policies. Please verify that the diagnosis code (ICD code) you have chosen demonstrates medical necessity for the test as documented in the physician’s patient record. The CMS web site is available to assist you with this verification. A properly executed Advance Beneficiary Notice (ABN) must be submitted with the specimen if medical necessity is not demonstrated by the ICD code chosen.

CPT Code Information

CPT Code

CPT Description

CPT Disclaimer
80307 Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry)  
80364 Opioids and Opiate Analogs, 5 or more (Definitive), Quantitative if Indicated

Keywords

DRUGS OF ABUSE

OXYCODONE (PERCODAN®)

PERCOCET

PERCODAN® (OXYCODONE)

Performing Laboratory Location

NorDx Laboratories

Clinical Significance

The opiate confirmation/quantitation by GC-MS is performed at an additional charge only if the oxycodone screen is positive.

 

This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment or forensic testing.

 

Intended Positives:

  • Oxycodone (Combunox, Endocet, Magnacet, Oxycontin, Percocet, Primlev, Roxicet, Roxicodone, Roxilox, Roxiprin, Tylox, Xolox)

 

Specific gravity, pH, creatinine and oxidants will be performed and reported at no additional charge to identify potential adulteration of the urine specimen.

Maximum Laboratory Time

4 Days

LOINC Code Information

19642-8